Emerging Technologies in Biocompatible Surface Modifying Additives: Quest for Physiologic Cardiopulmonary Bypass

E-ISSN： 1875-6174|2|4|295-302

ISSN： 1568-0169

Source： Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol.2, Iss.4, 2004-10, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hemostatic Defect of Cardiopulmonary Bypass

By Linden Matthew Dean

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 129-147

Springer Publishing Company

Access to resources Recommend Favorite

Chorea after Cardiopulmonary Bypass

European Neurology, Vol. 51, Iss. 1, 2004-01 ,pp. : 46-47

Karger

Access to resources Recommend Favorite

Cavopulmonary anastomosis without cardiopulmonary bypass

By Mostafa Ezzeldin A. El Midany Ashraf A.H. Zalat Mahmoud M. Helmy Ahmed

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 5, 2013-05 ,pp. : 649-653

Oxford University Press

Access to resources Recommend Favorite

What is a normal lactate level during cardiopulmonary bypass?

By Svenmarker Staffan Häggmark Sören Östman Margareta

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 5, 2006-10 ,pp. : 305-311

Informa Healthcare

Access to resources Recommend Favorite

Heparin, Platelet Aggregation, Neutrophils, and Cardiopulmonary Bypass

By Belcher P.R. Muriithi E.W. Milne E.M. Wanikiat P. Wheatley D.J. Armstrong R.A.

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 249-256

Elsevier

Access to resources Recommend Favorite